Itron, Inc. (NASDAQ:ITRI) Receives Average Recommendation of “Moderate Buy” from Brokerages

Itron, Inc. (NASDAQ:ITRI) has earned an average rating of “Moderate Buy” from the thirteen research firms that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, four have given a hold rating and eight have given a buy rating to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $131.2222.

ITRI has been the topic of several research analyst reports. Roth Mkm reissued a “buy” rating and issued a $136.00 target price on shares of Itron in a research report on Wednesday, April 29th. TD Cowen dropped their price target on shares of Itron from $145.00 to $130.00 and set a “buy” rating for the company in a research report on Wednesday, April 29th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Itron in a research note on Friday, May 8th. Stephens reiterated an “overweight” rating and issued a $130.00 price target on shares of Itron in a report on Wednesday, May 20th. Finally, Oppenheimer boosted their price objective on shares of Itron from $133.00 to $135.00 and gave the company an “outperform” rating in a research note on Thursday, April 16th.

Itron Stock Performance

NASDAQ ITRI opened at $85.11 on Monday. The business’s 50-day moving average price is $82.68 and its 200 day moving average price is $90.97. The company has a current ratio of 2.66, a quick ratio of 2.24 and a debt-to-equity ratio of 0.97. Itron has a twelve month low of $77.77 and a twelve month high of $142.00. The company has a market capitalization of $3.77 billion, a PE ratio of 13.57, a price-to-earnings-growth ratio of 0.75 and a beta of 1.32.

Itron (NASDAQ:ITRI) last posted its quarterly earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.26 by $0.23. Itron had a return on equity of 19.54% and a net margin of 12.31%.The company had revenue of $586.98 million during the quarter, compared to analysts’ expectations of $572.04 million. During the same quarter in the previous year, the business earned $1.52 EPS. The firm’s revenue was down 3.3% on a year-over-year basis. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. On average, research analysts predict that Itron will post 6.01 earnings per share for the current year.

Insider Buying and Selling

In other news, SVP Donald L. Reeves III sold 319 shares of Itron stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total value of $26,914.03. Following the transaction, the senior vice president directly owned 29,100 shares of the company’s stock, valued at $2,455,167. The trade was a 1.08% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP John F. Marcolini sold 322 shares of the business’s stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $84.37, for a total value of $27,167.14. Following the sale, the senior vice president owned 24,689 shares of the company’s stock, valued at $2,083,010.93. The trade was a 1.29% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders have sold 3,946 shares of company stock valued at $324,420. 1.77% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the business. EverSource Wealth Advisors LLC boosted its position in shares of Itron by 25.3% in the second quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock worth $53,000 after buying an additional 81 shares during the period. Northwestern Mutual Wealth Management Co. grew its holdings in Itron by 29.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock valued at $41,000 after purchasing an additional 101 shares in the last quarter. Xponance Inc. increased its stake in Itron by 3.2% during the 3rd quarter. Xponance Inc. now owns 3,757 shares of the scientific and technical instruments company’s stock worth $468,000 after buying an additional 115 shares during the period. Impact Partnership Wealth LLC increased its stake in Itron by 4.7% during the 1st quarter. Impact Partnership Wealth LLC now owns 2,661 shares of the scientific and technical instruments company’s stock worth $239,000 after buying an additional 119 shares during the period. Finally, Xponance LLC lifted its holdings in Itron by 3.2% in the 4th quarter. Xponance LLC now owns 3,877 shares of the scientific and technical instruments company’s stock worth $360,000 after buying an additional 120 shares in the last quarter. Hedge funds and other institutional investors own 96.19% of the company’s stock.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.